In 2012, orthopedic product sales exceeded $43 billion, an increase of $1.2 billion from 2011, according to ORTHOWORLD's orthopedic industry annual report.
Spinal Tech
The FDA has accepted BioMarin Pharmaceutical's biologics license application for Vimizim, an enzyme therapy that could be used to treat Mucopolysaccharidosis Type IVA or Morquio A Syndrome, according to Pipeline Review.
San Diego-based NuVasive launched its Maximum Access Surgery Posterior Lumbar Interbody Fusion procedure.
The Orthopedic and Rehabilitation panel for the U.S. Food and Drug Administration recommended changes to the pedicle screw's classification when it's used for treating degenerative disc disease and spondylolisthesis, according to a Medscape report.
Thousand Oaks, Calif.-based ECA Medical Instruments has moved to a new corporate headquarters in Ventura County, Calif.
Advertisement
Leesburg, Va.-based K2M has launched its MESA small stature spinal system for Australian, New Zealand and European markets.
Spinal Elements, based in Carlsbad, Calif., has licensed a portfolio of patents for accessing the lumbar spine and placing implants from a lateral approach.
Mazor Robotics' gross profit for the first quarter more than doubled from $1.9 million in 2012 to $4 million in the three month period ending March 31.
Spinal Elements, based in Carlsbad, Calif., has relocated its corporate headquarters to a 40,000-square-foot location. The company's original headquarters was 8,500 square feet.
The spinal implant market in the U.S. is now worth more than $5.5 billion, $1.5 billion of which is made up of minimally invasive spine implants, according to reports from iData Research.